Onera Health, an Eindhoven, Netherlands-based company focused on sleep diagnostic and monitoring solutions, raised €10.5M in Series B funding.
The round was led by Innovation Industries in close collaboration with Invest-NL and with existing investors imec.xpand, Jazz Pharmaceuticals, BOM and 15th Rock.
The company intends to use the funds to execute clinical studies and further commercialize its sleep diagnostics and monitoring products in Europe and the United States.
Led by Ruben de Francisco, Founder, CTO & interim CEO, Onera provides sleep diagnostic and remote monitoring solutions and services poised to help millions of people struggling with sleep-related ailments, while also impacting other medical fields by monitoring a variety of chronic conditions, ultimately improving the health and quality of life for patients around the world.
The company has recently obtained the CE mark for its first product, an innovative polysomnography (PSG) system.
Onera recently relocated its headquarters to the Brainport region in Eindhoven, the Netherlands, while maintaining commercial operations in the United States.
FinSMEs
30/07/2021